Achieving Value in Orthopedic Surgery: Clinical Pathways, Bundled Payment Programs, and Proactive Risk Assessment for Elective Orthopedic Procedures

  • Alana E. SigmundEmail author
  • Catherine H. MacLean


Bundled payment models hold providers accountable for both the quality and cost of care provided to the patients. Proactive risk assessment can improve quality and reduce the costs of care. Numerous risk factors may impact patient outcomes. Personalized care plans aimed at reducing or eliminating risks are key to improving patient outcomes. Opportunities to provide personalized risk modification exist before, during, and after the elective surgical admission. A variety of validated tools exist to assist providers in assessing risk in patients planning an elective procedure.


Value Clinical Pathways Bundled Payment Modifiable Risks Risk Assessment Risk Optimization, Orthopedic Surgery, Readmissions 


  1. 1.
    McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–45.CrossRefGoogle Scholar
  2. 2.
    Wenger NS, Solomon DH, Roth CP, MacLean CH, Saliba D, Kamberg CJ, et al. The quality of medical care provided to vulnerable community-dwelling older patients. Ann Intern Med. 2003;139(9):740–7.CrossRefGoogle Scholar
  3. 3.
    Dieleman JL, Baral R, Birger M, Bui AL, Bulchis A, Chapin A, et al. US spending on personal health care and public health, 1996–2013. JAMA. 2016;316(24):2627–46.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Institute of Medicine. In: Smith M, et al., editors. Best care at lower cost: the path to continuously learning health care in America. Washington, DC: The National Academies Press; 2013. p. 436.Google Scholar
  5. 5.
    Huse DM, Marder WD. What are the leading drivers of employer healthcare spending growth? Ann Arbor: Truven Health Analytics; 2013.Google Scholar
  6. 6.
    Dieleman JL, Squires E, Bui AL, Campbell M, Chapin A, Hamavid H, et al. Factors associated with increases in US health care spending, 1996–2013. JAMA. 2017;318(17):1668–78.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Barbour KE, Helmick CG, Boring M, Qin J, Pan L, Hootman JM. Obesity trends among US adults with doctor-diagnosed arthritis 2009–2014. Arthritis Care Res (Hoboken). 2017;69(3):376–83.CrossRefGoogle Scholar
  8. 8.
    Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–5.CrossRefGoogle Scholar
  9. 9.
    Blue Cross Blue Shield Association. A study of cost variations for knee and hip replacement surgeries in the U.S. 2015 [cited 2018 05/21]. Available from:
  10. 10.
    Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477–81.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Ryan AM, Tompkins CP. Efficiency and value in healthcare: linking cost and quality measures. Washington, DC: National Quality Forum; 2014.Google Scholar
  12. 12.
    Centers for Medicare and Medicaid Services. Comprehensive care for joint replacement model. May 2, 2018. Available from:
  13. 13.
    Comprehensive care for joint replacement model. [May 1, 2018]. Available from:
  14. 14.
    Centers for Medicare & Medicaid Services. BPCI Advanced; 2018. Available from:
  15. 15.
    Institute of Medicine. Rewarding provider performance aligning incentives in Medicare. Washington, DC: National Academies Press; 2006.Google Scholar
  16. 16.
    Hofstede SN, Gademan MG, Vliet Vlieland TP, Nelissen RG, Marang-van de Mheen PJ. Preoperative predictors for outcomes after total hip replacement in patients with osteoarthritis: a systematic review. BMC Musculoskelet Disord. 2016;17:212.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hofstede SN, Gademan MGJ, Stijnen T, Nelissen R, Marang-van de Mheen PJ. The influence of preoperative determinants on quality of life, functioning and pain after total knee and hip replacement: a pooled analysis of Dutch cohorts. BMC Musculoskelet Disord. 2018;19(1):68.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Tilbury C, Haanstra TM, Verdegaal SHM, Nelissen R, de Vet HCW, Vliet Vlieland TPM, et al. Patients’ pre-operative general and specific outcome expectations predict postoperative pain and function after total knee and total hip arthroplasties. Scand J Pain. 2018;18(3):457–66.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Berliner JL, Brodke DJ, Chan V, SooHoo NF, Bozic KJ. John Charnley Award: preoperative patient-reported outcome measures predict clinically meaningful improvement in function after THA. Clin Orthop Relat Res. 2016;474(2):321–9.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4 Pt 1):1005–26.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Oldmeadow LB, McBurney H, Robertson VJ. Predicting risk of extended inpatient rehabilitation after hip or knee arthroplasty. J Arthroplasty. 2003;18(6):775–9.CrossRefGoogle Scholar
  22. 22.
    Hansen VJ, Gromov K, Lebrun LM, Rubash HE, Malchau H, Freiberg AA. Does the risk assessment and prediction tool predict discharge disposition after joint replacement? Clin Orthop Relat Res. 2015;473(2):597–601.CrossRefGoogle Scholar
  23. 23.
    Slover J, Mullaly K, Karia R, Bendo J, Ursomanno P, Galloway A, et al. The use of the risk assessment and prediction tool in surgical patients in a bundled payment program. Int J Surg. 2017;38:119–22.CrossRefGoogle Scholar
  24. 24.
    Doran JP, Zabinski SJ. Bundled payment initiatives for Medicare and non-Medicare total joint arthroplasty patients at a community hospital: bundles in the real world. J Arthroplasty. 2015;30(3):353–5.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Nussenbaum FD, Rodriguez-Quintana D, Fish SM, Green DM, Cahill CW. Implementation of preoperative screening criteria lowers infection and complication rates following elective total hip arthroplasty and total knee arthroplasty in a veteran population. J Arthroplasty. 2018;33(1):10–3.CrossRefGoogle Scholar
  26. 26.
    D’Apuzzo MR, Novicoff WM, Browne JA. The John Insall Award: morbid obesity independently impacts complications, mortality, and resource use after TKA. Clin Orthop Relat Res. 2015;473(1):57–63.CrossRefGoogle Scholar
  27. 27.
    Arsoy D, Woodcock JA, Lewallen DG, Trousdale RT. Outcomes and complications following total hip arthroplasty in the super-obese patient, BMI > 50. J Arthroplasty. 2014;29(10):1899–905.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    DeFroda SF, Rubin LE, Jenkins DR. Modifiable risk factors in total joint arthroplasty: a pilot study. R I Med J (2013). 2016;99(5):28–31.Google Scholar
  29. 29.
    Smith TO, Aboelmagd T, Hing CB, MacGregor A. Does bariatric surgery prior to total hip or knee arthroplasty reduce post-operative complications and improve clinical outcomes for obese patients? Systematic review and meta-analysis. Bone Joint J. 2016;98-B(9):1160–6.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Huang R, Greenky M, Kerr GJ, Austin MS, Parvizi J. The effect of malnutrition on patients undergoing elective joint arthroplasty. J Arthroplasty. 2013;28(8 Suppl):21–4.CrossRefGoogle Scholar
  31. 31.
    Botella-Carretero JI, Iglesias B, Balsa JA, Arrieta F, Zamarron I, Vazquez C. Perioperative oral nutritional supplements in normally or mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clin Nutr. 2010;29(5):574–9.CrossRefGoogle Scholar
  32. 32.
    Singh JA. Smoking and outcomes after knee and hip arthroplasty: a systematic review. J Rheumatol. 2011;38(9):1824–34.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Duchman KR, Gao Y, Pugely AJ, Martin CT, Noiseux NO, Callaghan JJ. The effect of smoking on short-term complications following total hip and knee arthroplasty. J Bone Joint Surg Am. 2015;97(13):1049–58.CrossRefGoogle Scholar
  34. 34.
    Thomsen T, Villebro N, Moller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2014;(3):CD002294.Google Scholar
  35. 35.
    Poon A, Owen J, Gijsbers AJ. Identification of at-risk drinkers in an orthopaedic inpatient population. Aust N Z J Surg. 1994;64(11):775–9.CrossRefGoogle Scholar
  36. 36.
    Williams G, Daly M, Proude EM, Kermode S, Davis M, Barling J, et al. The influence of alcohol and tobacco use in orthopaedic inpatients on complications of surgery. Drug Alcohol Rev. 2008;27(1):55–64.CrossRefGoogle Scholar
  37. 37.
    Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol use disorders identification test. Arch Intern Med. 1998;158(16):1789–95.CrossRefGoogle Scholar
  38. 38.
    Armaghani SJ, Lee DS, Bible JE, Archer KR, Shau DN, Kay H, et al. Preoperative opioid use and its association with perioperative opioid demand and postoperative opioid independence in patients undergoing spine surgery. Spine (Phila Pa 1976). 2014;39(25):E1524–30.CrossRefGoogle Scholar
  39. 39.
    Pivec R, Issa K, Naziri Q, Kapadia BH, Bonutti PM, Mont MA. Opioid use prior to total hip arthroplasty leads to worse clinical outcomes. Int Orthop. 2014;38(6):1159–65.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Bedard NA, DeMik DE, Dowdle SB, Callaghan JJ. Trends and risk factors for prolonged opioid use after unicompartmental knee arthroplasty. Bone Joint J. 2018;100-B(1 Supple A):62–7.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Dwyer CL, Soong M, Hunter A, Dashe J, Tolo E, Kasparyan NG. Prospective evaluation of an opioid reduction protocol in hand surgery. J Hand Surg Am. 2018;43(6):516–522.e1.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Hyer L, Scott C, Mullen CM, McKenzie LC, Robinson JS. Randomized double-blind placebo trial of duloxetine in perioperative spine patients. J Opioid Manag. 2015;11(2):147–55.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043–9.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Duceppe E, Parlow J, MacDonald P, Lyons K, McMullen M, Srinathan S, et al. Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol. 2017;33(1):17–32.CrossRefGoogle Scholar
  45. 45.
    Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2014;130(24):e278–333.PubMedGoogle Scholar
  46. 46.
    Graham MM, Sessler DI, Parlow JL, Biccard BM, Guyatt G, Leslie K, et al. Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery. Ann Intern Med. 2018;168(4):237–44.CrossRefGoogle Scholar
  47. 47.
    Andersson C, Merie C, Jorgensen M, Gislason GH, Torp-Pedersen C, Overgaard C, et al. Association of beta-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. JAMA Intern Med. 2014;174(3):336–44.CrossRefGoogle Scholar
  48. 48.
    Jorgensen ME, Torp-Pedersen C, Gislason GH, Jensen PF, Berger SM, Christiansen CB, et al. Time elapsed after ischemic stroke and risk of adverse cardiovascular events and mortality following elective noncardiac surgery. JAMA. 2014;312(3):269–77.CrossRefGoogle Scholar
  49. 49.
    Christiansen MN, Andersson C, Gislason GH, Torp-Pedersen C, Sanders RD, Foge Jensen P, et al. Risks of cardiovascular adverse events and death in patients with previous stroke undergoing emergency noncardiac, nonintracranial surgery: the importance of operative timing. Anesthesiology. 2017;127(1):9–19.CrossRefGoogle Scholar
  50. 50.
    Pincus D, Ravi B, Wasserstein D, Huang A, Paterson JM, Nathens AB, et al. Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA. 2017;318(20):1994–2003.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Browne JA, Cancienne JM, Novicoff WM, Werner BC. Removal of an infected hip arthroplasty is a high-risk surgery: putting morbidity into context with other major nonorthopedic operations. J Arthroplasty. 2017;32(9):2834–41.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Mundi S, Pindiprolu B, Simunovic N, Bhandari M. Similar mortality rates in hip fracture patients over the past 31 years. Acta Orthop. 2014;85(1):54–9.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Harris AH, Bowe TR, Gupta S, Ellerbe LC, Giori NJ. Hemoglobin A1C as a marker for surgical risk in diabetic patients undergoing total joint arthroplasty. J Arthroplasty. 2013;28(8 Suppl):25–9.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Edwards PK, Mears SC, Stambough JB, Foster SE, Barnes CL. Choices, compromises, and controversies in total knee and total hip arthroplasty modifiable risk factors: what you need to know. J Arthroplasty. 2018;33(10):3101–6.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Stryker LS, Abdel MP, Morrey ME, Morrow MM, Kor DJ, Morrey BF. Elevated postoperative blood glucose and preoperative hemoglobin A1C are associated with increased wound complications following total joint arthroplasty. J Bone Joint Surg Am. 2013;95(9):808–14, S1-2.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Miric A, Inacio MC, Namba RS. The effect of chronic kidney disease on total hip arthroplasty. J Arthroplasty. 2014;29(6):1225–30.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Miric A, Inacio MC, Namba RS. Can total knee arthroplasty be safely performed in patients with chronic renal disease? Acta Orthop. 2014;85(1):71–8.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Tsai CH, Muo CH, Hung CH, Lin TL, Wang TI, Fong YC, et al. Disorder-related risk factors for revision total hip arthroplasty after hip hemiarthroplasty in displaced femoral neck fracture patients: a nationwide population-based cohort study. J Orthop Surg Res. 2016;11(1):66.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Lizaur-Utrilla A, Martinez-Mendez D, Collados-Maestre I, Marco-Gomez L, Lopez-Prats FA. Elective total knee arthroplasty in patients with end-stage renal disease: is it a safe procedure? J Arthroplasty. 2016;31(10):2152–5.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Sakaura H, Miwa T, Yamashita T, Kuroda Y, Ohwada T. Lifestyle-related diseases affect surgical outcomes after posterior lumbar interbody fusion. Global Spine J. 2016;6(1):2–6.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Chikawa T, Sakai T, Bhatia NN, Miyagi R, Sairyo K, Goda Y, et al. Clinical outcomes of spinal surgery in patients treated with hemodialysis. J Spinal Disord Tech. 2013;26(6):321–4.CrossRefGoogle Scholar
  62. 62.
    Writing Committee for the for the VISION Study Investigators, Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2017;317(16):1642–51.CrossRefGoogle Scholar
  63. 63.
    Leclerc JR, Gent M, Hirsh J, Geerts WH, Ginsberg JS. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group. Arch Intern Med. 1998;158(8):873–8.CrossRefGoogle Scholar
  64. 64.
    Lapidus LJ, Ponzer S, Pettersson H, de Bri E. Symptomatic venous thromboembolism and mortality in orthopaedic surgery – an observational study of 45 968 consecutive procedures. BMC Musculoskelet Disord. 2013;14:177.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Fawi HMT, Saba K, Cunningham A, Masud S, Lewis M, Hossain M, et al. Venous thromboembolism in adult elective spinal surgery: a tertiary centre review of 2181 patients. Bone Joint J. 2017;99-b(9):1204–9.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Wang T, Yang SD, Huang WZ, Liu FY, Wang H, Ding WY. Factors predicting venous thromboembolism after spine surgery. Medicine (Baltimore). 2016;95(52):e5776.CrossRefGoogle Scholar
  67. 67.
    Russell LA, Sigmund AE, Szymonifka J, Jawetz ST, Grond SE, Dey SA, et al. Does my patient have a pulmonary embolism? The Wells vs. PISA 2 rule in orthopedic patients. J Thromb Thrombolysis. 2018;45(3):417–22.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Bass AR, Fields KG, Goto R, Turissini G, Dey S, Russell LA. Clinical decision rules for pulmonary embolism in hospitalized patients: a systematic literature review and meta-analysis. Thromb Haemost. 2017;117(11):2176–85.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Brenner DJ. Medical imaging in the 21st century--getting the best bang for the rad. N Engl J Med. 2010;362(10):943–5.CrossRefGoogle Scholar
  70. 70.
    Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320(3):143–9.CrossRefGoogle Scholar
  71. 71.
    Ramme AJ, Iturrate E, Dweck E, Steiger DJ, Hutzler LH, Fang Y, et al. End tidal carbon dioxide as a screening tool for computed tomography angiogram in postoperative orthopaedic patients suspected of pulmonary embolism. J Arthroplasty. 2016;31(10):2348–52.CrossRefGoogle Scholar
  72. 72.
    Sigmund AE, Fang Y, Chin M, Reynolds HR, Horwitz LI, Dweck E, et al. Ostoperative tachycardia: clinically meaningful or benign consequence of orthopedic surgery? Mayo Clin Proc. 2017;92(1):98–105.CrossRefGoogle Scholar
  73. 73.
    Fineberg SJ, Nandyala SV, Kurd MF, Marquez-Lara A, Noureldin M, Sankaranarayanan S, et al. Incidence and risk factors for postoperative ileus following anterior, posterior, and circumferential lumbar fusion. Spine J. 2014;14(8):1680–5.CrossRefGoogle Scholar
  74. 74.
    Parvizi J, Han SB, Tarity TD, Pulido L, Weinstein M, Rothman RH. Postoperative ileus after total joint arthroplasty. J Arthroplasty. 2008;23(3):360–5.CrossRefGoogle Scholar
  75. 75.
    Sibia US, Mandelblatt AE, Callanan MA, MacDonald JH, King PJ. Incidence, risk factors, and costs for hospital returns after total joint arthroplasties. J Arthroplasty. 2017;32(2):381–5.CrossRefGoogle Scholar
  76. 76.
    Al Maaieh MA, Du JY, Aichmair A, Huang RC, Hughes AP, Cammisa FP, et al. Multivariate analysis on risk factors for postoperative ileus after lateral lumbar interbody fusion. Spine (Phila Pa 1976). 2014;39(8):688–94.CrossRefGoogle Scholar
  77. 77.
    Duchman KR, Pugely AJ, Martin CT, Gao Y, Bedard NA, Callaghan JJ. Operative time affects short-term complications in total joint arthroplasty. J Arthroplasty. 2017;32(4):1285–91.CrossRefGoogle Scholar
  78. 78.
    Carreon LY, Puno RM, Dimar JR 2nd, Glassman SD, Johnson JR. Perioperative complications of posterior lumbar decompression and arthrodesis in older adults. J Bone Joint Surg Am. 2003;85-a(11):2089–92.CrossRefGoogle Scholar
  79. 79.
    Carroll K, Dowsey M, Choong P, Peel T. Risk factors for superficial wound complications in hip and knee arthroplasty. Clin Microbiol Infect. 2014;20(2):130–5.CrossRefGoogle Scholar
  80. 80.
    Triantafyllopoulos G, Stundner O, Memtsoudis S, Poultsides LA. Patient, surgery, and hospital related risk factors for surgical site infections following total hip arthroplasty. ScientificWorldJournal. 2015;2015:979560.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    van Walraven C, Dhalla IA, Bell C, Etchells E, Stiell IG, Zarnke K, et al. Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. CMAJ. 2010;182(6):551–7.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Donze JD, Williams MV, Robinson EJ, Zimlichman E, Aujesky D, Vasilevskis EE, et al. International validity of the HOSPITAL score to predict 30-day potentially avoidable hospital readmissions. JAMA Intern Med. 2016;176(4):496–502.CrossRefPubMedPubMedCentralGoogle Scholar
  83. 83.
    Kim CS, Flanders SA. In the clinic. Transitions of care. Ann Intern Med. 2013;158(5 Pt 1):Itc3–1.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Minhas SV, Kester BS, Lovecchio FC, Bosco JA. Nationwide 30-day readmissions after elective orthopedic surgery: reasons and implications. J Healthc Qual. 2017;39(1):34–42.CrossRefPubMedPubMedCentralGoogle Scholar
  85. 85.
    Merkow RP, Ju MH, Chung JW, Hall BL, Cohen ME, Williams MV, et al. Underlying reasons associated with hospital readmission following surgery in the United States. JAMA. 2015;313(5):483–95.CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    Basques BA, Tetreault MW, Della Valle CJ. Same-day discharge compared with inpatient hospitalization following hip and knee arthroplasty. J Bone Joint Surg Am. 2017;99(23):1969–77.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Ravi B, Nan Z, Schwartz AJ, Clarke HD. Fall risk score at the time of discharge predicts readmission following total joint arthroplasty. J Arthroplasty. 2017;32(7):2077–81.CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    Vasquez RA, Chotai S, Freeman TH, Kay HF, Cheng JS, McGirt MJ, et al. Impact of discharge disposition on 30-day readmissions following elective spine surgery. Neurosurgery. 2017;81(5):772–8.PubMedPubMedCentralGoogle Scholar
  89. 89.
    Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation (YNHHSC/CORE). 2017 procedure-specific measures updates and specifications report hospital-level 30-day risk-standardized readmission measures: isolated Coronary artery bypass graft (CABG) surgery – version 4.0, elective primary Total hip arthroplasty (THA) and/or Total knee arthroplasty (TKA) – version 6.0. 2017 April 20, 2018. Available from:

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of MedicineHospital for Special Surgery, Weill Medical College of CornellNew YorkUSA
  2. 2.Hospital for Special Surgery, Center for the Advancement of Value in Musculoskeletal CareNew YorkUSA

Personalised recommendations